Article
HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer.
Cancer immunology, immunotherapy : CII - 1 Oct 1997
Ogoshi K, Tajima T, Mitomi T, Makuuchi H, Tsuji K
Abstract excerpt
Our previous studies have shown that HLA-DR4 and -B52 antigens are associated with an increased risk of lymph node metastasis in patients with gastric cancer. We hypothesized that a putative HLA antigen, correlated with a low risk of lymph node metastasis, may also be correlated with the response to anticancer therapy. The microcytotoxicity assay was used to examine 49 HLA antigens of the A, B, C, DR, and DQ...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
